An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)

NCT00200447 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: carbidopa/l-dopa
DRUG: carbidopa/l-dopa/entacapone
DRUG: Stalevo
PROCEDURE: [123I]-IBZM imaging

Sponsor

Molecular NeuroImaging